A ramped-up immune response may play a major role in autism disorders, according to a new study from UAB and Johns Hopkins.
A new UAB study reports on a potential new treatment for frontotemporal dementia, the second most common type after Alzheimer’s disease.
The multi-project research targets key molecular steps of immune cell-fate decisions after virus infection.
Research revealing new evidence about the role of the spleen following heart attack will be honored during the AHA scientific meeting Nov. 15-19.
The addition of five new research scientists takes UAB’s Department of Anesthesiology to new heights.
The “repurposing of verapamil as a beta cell survival therapy in type 1 diabetes” trial will test an approach different from any current diabetes treatment.
It has been more than 30 years since the last major advancement in prostate cancer screening technology, and the latest advancement is now available in the Southeast only at UAB.
Keshav K. Singh, Ph.D., an expert on the roles of mitochondria in cancer, mitochondrial disease and aging, is one of 12 extramural researchers invited to a National Cancer Institute Mitochondrial Information Transfer Strategic Workshop.
Two highly acclaimed cancer researchers, Ravi Bhatia, M.D., and Smita Bhatia, M.D., MPH, will join UAB in January 2015.
Sixteen clinical centers and 30 hospitals will enroll up to 5,700 pregnant women to evaluate the benefits and harms of pharmacologic treatment of mild chronic hypertension in pregnancy.